Singapore markets closed

Actavia Life Sciences, Inc. (RASP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0169+0.0025 (+17.36%)
At close: 12:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.04M
Enterprise value 13.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA 24.70

Trading information

Stock price history

Beta (5Y monthly) -60.24
52-week change 3196.49%
S&P500 52-week change 326.49%
52-week high 30.0390
52-week low 30.0057
50-day moving average 30.0102
200-day moving average 30.0111

Share statistics

Avg vol (3-month) 31.2k
Avg vol (10-day) 36.19k
Shares outstanding 5771.81M
Implied shares outstanding 6771.81M
Float 8771.65M
% held by insiders 185.19%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23.25:1
Last split date 320 Sept 2016

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-6,109.99%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-4.44M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.18k
Total cash per share (mrq)0
Total debt (mrq)225.7k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.01
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-54.42k
Levered free cash flow (ttm)1.53M